Norway In-Vitro Diagnostic Market is predicted to reach USD 989.38 Million by 2030

According to the study by Next Move Strategy Consulting, the Norway In-Vitro Diagnostics Market size is predicted to reach USD 989.38 million, at a CAGR of 4.7% by 2030.

Request a FREE Sample: https://www.nextmsc.com/norway-in-vitro-diagnostic-market/request-sample

The ongoing development in Norway's healthcare sector, significantly boosts the market for in-vitro diagnostics.

The rise in the prevalence of chronic diseases stimulates the need for sophisticated diagnostic techniques such as in-vitro diagnostics.

The promising players operating in the Norway in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.